OVARIAN CLEAR CELL ADENOCARCINOFIBROMA
Clinical trials for OVARIAN CLEAR CELL ADENOCARCINOFIBROMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL ADENOCARCINOFIBROMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL ADENOCARCINOFIBROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo schedule tested to improve ovarian cancer outcomes
Disease control OngoingThis study tested whether giving the chemotherapy drug paclitaxel weekly works better than the standard every-3-weeks schedule for people with advanced ovarian, peritoneal, or fallopian tube cancer. All participants also received carboplatin, and some received the targeted drug b…
Matched conditions: OVARIAN CLEAR CELL ADENOCARCINOFIBROMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:24 UTC
-
New hope for recurrent ovarian cancer: drug combo extends life?
Disease control OngoingThis study looked at whether adding the drug bevacizumab to standard chemotherapy after surgery helps people with ovarian, peritoneal, or fallopian tube cancer that has come back live longer. Over 1,000 participants were randomly assigned to receive chemo alone or chemo plus beva…
Matched conditions: OVARIAN CLEAR CELL ADENOCARCINOFIBROMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC